Phase I/II trial of axalimogene filolisbac (ADXS-HPV) prior to surgery in patients with surgically treatable cervical cancer
Latest Information Update: 26 Feb 2023
At a glance
- Drugs Axalimogene filolisbac (Primary)
- Indications Cervical cancer
- Focus Adverse reactions; Therapeutic Use
- 19 Jan 2023 According to an Ayala Pharmaceuticals media release, Advaxis merged with Ayala Pharmaceuticals to form Ayala Pharmaceuticals.
- 19 Feb 2014 New trial record